Novel Nor-Homo- and Spiro-Oxetan- Steroids Target the Human Androgen Receptor and Act as Antiandrogens

Publisher： Bentham Science Publishers

E-ISSN： 1875-533x|22|9|1156-1167

ISSN： 0929-8673

Source： Current Medicinal Chemistry, Vol.22, Iss.9, 2015-03, pp. : 1156-1167

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Androgen Receptor Antagonists (Antiandrogens) Structure-Activity Relationships

By  

Current Medicinal Chemistry, Vol. 7, Iss. 2, 2000-02 ,pp. : 211-247

Bentham Science Publishers

Access to resources Recommend Favorite

Androgen Receptor in Human Health: A Potential Therapeutic Target

By  

Current Drug Targets, Vol. 13, Iss. 14, 2012-12 ,pp. : 1907-1916

Bentham Science Publishers

Access to resources Recommend Favorite

Editorial (Hot Topic: Androgen Receptor and Prostate Cancer: New Insights in an Old Target Translate into Novel Therapeutic Strategies)

By  

Current Drug Targets, Vol. 14, Iss. 4, 2013-01 ,pp. : 399-400

Bentham Science Publishers

Access to resources Recommend Favorite

The androgen receptor as a therapeutic target in prostate cancer

By Visakorpi T.  

Expert Opinion on Therapeutic Targets, Vol. 4, Iss. 1, 2000-02 ,pp. : 65-71

Informa Healthcare

Access to resources Recommend Favorite

New Approaches to Target the Androgen Receptor and STAT3 for Prostate Cancer Treatments

By  

Mini Reviews in Medicinal Chemistry, Vol. 9, Iss. 3, 2009-03 ,pp. : 395-400

Bentham Science Publishers

Access to resources Recommend Favorite